Neoanhydropodophyllol
Neoanhydropodophyllol is a cyclolignan derivative, with antineoplastic activity. Neoanhydropodophyllol displays cytotoxicity against several cancer cells (leukemia, lung carcinoma and colon carcinoma) [1].
Product Specifications
CAS Number
[62287-47-2]
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Others
Type
Natural Products
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/neoanhydropodophyllol.html
Concentration
10mM
Purity
99.61
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC[C@@H]1[C@]2([H])C3=CC(OCO4)=C4C=C3[C@@H](C5=CC(OC)=C(OC)C(OC)=C5)[C@@]1([H])CO2
Molecular Formula
C22H24O7
Molecular Weight
400.42
Precautions
H315, H319
References & Citations
[1]M Gordaliza, et al. Cytotoxic cyclolignans related to podophyllotoxin. Farmaco. 2001 Apr;56 (4) :297-304.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MRE11A (Double-Strand Break Repair Protein MRE11, MRE11 Homolog, Double Strand Break Repair Nuclease)
CD4 (CD4 Receptor, CD4mut, T Cell Surface Antigen T4/Leu3, T Cell Surface Glycoprotein CD4 (MaxLight 490)
